Mount Sinai lab colleagues have been involved with major breakthroughs over the past year because testing was central to learning about the COVID-19 pandemic.
At the start of the pandemic, our lab teams rapidly transformed their operations to expand and modify testing for COVID-19 as the number of patients affected grew and the standards for testing morphed. They quickly became a national leader in providing antibody testing and treatment, receiving Emergency Use Authorization for a very early version of the test which identified candidates for antibody plasma donation in early treatments.
Many studies about COVID-19 antibody responses in our patients were possible because of the coordination and hard work of the lab teams across Mount Sinai. They were also integral to establishing the Mount Sinai COVID-19 PCR Saliva Testing program as a part of the New York State Excelsior Pass program.
The Mount Sinai lab team is made up of many different people working in coordination across the Health System, including histologists, lab technologists, quality experts, lab information technology experts, physicians, autopsy and morgue teams, managers, and many more. Their continued dedication and collaboration is vital to keeping our community safe and well.